374
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Phytantriol based liquid crystal provide sustained release of anticancer drug as a novel embolic agent

, , , , , , & show all
Pages 307-316 | Received 09 Dec 2014, Accepted 07 May 2015, Published online: 02 Jun 2015

References

  • Turcotte S, Dematteo RP. Resection versus transplantation for early hepatocellular carcinoma: more art than science. Ann Surg 2012;256:892–3
  • Wu XZ, Xie GR, Chen D. Hypoxia and hepatocellular carcinoma: the therapeutic target for hepatocellular carcinoma. J Gastroenterol Hepatol 2007;22:1178–82
  • Hsieh MY, Lin ZY, Chuang WL. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization. Kaohsiung J Med Sci 2011;27:314–22
  • Llovet JM, Real MI, Montaña X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734–9
  • Feng L, Kienitz BA, Matsumoto C, et al. Feasibility of using hyperosmolar mannitol as a liquid tumor embolization agent. Am J Neuroradiol 2005;26:1405–12
  • Schwaner SL, Haug SB, Matsumoto AH. Overview of embolotherapy: agents, indications, applications, and nursing management. Perioperat Nurs Clin 2010;5:137–76
  • Scartozzi M, Baroni GS, Faloppi L, et al. Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis. J Exp Clin Cancer Res 2010;29:164
  • Dai J, Kim J-C. Photo responsive monoolein cubic phase containing coumarin-Tween 20 conjugates. Drug Dev Ind Pharm 2013;39:1457–63
  • Helledi LS, Schubert L. Release kinetics of acyclovir from a suspension of acyclovir incorporated in a cubic phase delivery system. Drug Dev Ind Pharm 2001;27:1073–81
  • Kwon TK, Kim J-C. Monoolein cubic phase containing acidic proteinoid: pH-dependent release. Drug Dev Ind Pharm 2011;37:56–61
  • Costa-Balogh FO, Sparr E, Sousa JJ, Pais AC. Drug release from lipid liquid crystalline phases: relation with phase behavior. Drug Dev Ind Pharm 2010;36:470–81
  • Wadsten-Hindrichsen P, Bender J, Unga J, Engström S. Aqueous self-assembly of phytantriol in ternary systems: effect of monoolein, distearoylphosphatidylglycerol and three water-miscible solvents. J Colloid Interface Sci 2007;315:701–13
  • Li Y, Wei P, Li J, Li L. Pharmacokinetic analysis and optimization of hydroxycamptothecin-loaded nanoparticles for liver targeting. Drug Dev Ind Pharm 2012;38:837–47
  • Opanasopit P, Ngawhirunpat T, Chaidedgumjorn A, et al. Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system. Eur J Pharm Biopharm 2006;64:269–76
  • Mottu F, Gailloud P, Massuelle D, et al. In vitro assessment of new embolic liquids prepared from preformed polymers and water-miscible solvents for aneurysm treatment. Biomaterials 2000;21:803–11
  • Mottu F, Rüfenacht DA, Laurent A, Doelker E. Iodine-containing cellulose mixed esters as radiopaque polymers for direct embolization of cerebral aneurysms and arteriovenous malformations. Biomaterials 2002;23:121–31
  • Hu W, Zhang C, Hu W, et al. Pharmacokinetics, tissue distribution, and the lactone/carboxylate equilibrium of hydroxycamptothecin delivered via aerosol in mice. Fitoterapia 2012;83:1291–8
  • Rizwan SB, Hanley T, Boyd BJ, et al. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: characterisation, swelling and release kinetics. J Pharm Sci 2009;98:4191–204
  • Opanasopit P, Yokoyama M, Watanabe M, et al. Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting. Pharm Res 2004;21:2001–8
  • Hong M, Zhu S, Jiang Y, et al. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin. J Control Release 2009;133:96–102
  • Li X, Liu W, Ye G, et al. Thermosensitive N-isopropylacrylamide-N-propylacrylamide-vinyl pyrrolidone terpolymers: synthesis, characterization and preliminary application as embolic agents. Biomaterials 2005;26:7002–11
  • Gao Z, Ding P, Zhang L, et al. Study of a pingyangmycin delivery system: Zein/Zein-SAIB in situ gels. Int J Pharm 2007;328:57–64
  • Kazekawa K, Iwata H, Shimozuru T, et al. Nontoxic embolic liquids for treatment of arteriovenous malformations. J Biomed Mater Res 1997;38:79–86
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63
  • Rassweiler J, Prager P, Haferkamp A, et al. Transarterial nephrectomy: the current status of experimental and clinical studies. J Endourol 2008;22:767–82
  • Adamsbaum C, Mascard E, Guinebretière JM, et al. Intralesional Ethibloc injections in primary aneurysmal bone cysts: an efficient and safe treatment. Skelet Radiol 2003;32:559–66
  • Vernon B, Birdno M, Preul MC. In situ gelling self-reactive materials for embolization. US 8048407 B2; 2011
  • Saw CL, Olivo M, Chin WW, et al. Superiority of N-methyl pyrrolidone over albumin with hypericin for fluorescence diagnosis of human bladder cancer cells implanted in the chick chorioallantoic membrane model. J Photochem Photobiol B Biol 2007;86:207–18
  • Dudeck O, Jordan O, Hoffmann KT, et al. Organic solvents as vehicles for precipitating liquid embolics: a comparative angiotoxicity study with superselective injections of swine rete mirabile. Am J Neuroradiol 2006;27:1900–6
  • Dudeck O, Jordan O, Hoffmann KT, et al. Embolization of experimental wide-necked aneurysms with iodine-containing polyvinyl alcohol solubilized in a low-angiotoxicity solvent. Am J Neuroradiol 2006;27:1849–55
  • Nguyen TH, Hanley T, Porter CJ, et al. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media. J Pharm Pharmacol 2010;62:844–55
  • Yang J, Ni B, Liu J, et al. Application of liposome-encapsulated hydroxycamptothecin in the prevention of epidural scar formation in New Zealand white rabbits. Spine J 2011;11:218–23
  • Zhu L, Ni B, Liu J, et al. Hydroxycamptothecin liposomes inhibit collagen secretion and induce fibroblast apoptosis in a postlaminectomy rabbit model. Eur J Orthop Surg Traumatol 2013;23:S85–91
  • Han K, Pan X, Chen M, et al. Phytantriol-based inverted type bicontinuous cubic phase for vascular embolization and drug sustained release. Eur J Pharm Sci 2010;41:692–9
  • Lara MG, Bentley MV, Collett JH. In vitro drug release mechanism and drug loading studies of cubic phase gels. Int J Pharm 2005;293:241–50
  • Chang C-M, Bodmeier R. Effect of dissolution media and additives on the drug release from cubic phase delivery systems. J Control Release 1997;46:215–22
  • Dokoumetzidis A, Papadopoulou V, Macheras P. Analysis of dissolution data using modified versions of Noyes-Whitney equation and the Weibull function. Pharm Res 2006;23:256–61
  • Phelps J, Bentley MV, Lopes LB. In situ gelling hexagonal phases for sustained release of an anti-addiction drug. Colloids Surf B Biointerfaces 2011;87:391–8
  • Chen Y, Li G, Wu X, et al. Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment. Biol Pharm Bull 2008;31:118–25
  • Han K, Wang Z, Peng X, et al. Transarterial chemoembolization using docetaxel-loaded phytantriol cubic phase precursor for the treatment of hepatocellular carcinoma. J Pharm Sci 2011;100:2240–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.